Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity Statement

v3.20.2
Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
AOCI Attributable to Parent
Beginning balance (shares) at Dec. 31, 2018   24,824,746        
Beginning balance at Dec. 31, 2018   $ 24,825 $ 56,427,928 $ (28,670,095) $ 255,116 $ 28,037,774
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (shares)   18,515        
Exercise of stock options $ 26,417 $ 18 26,399      
Stock issuance costs (1,011)   (1,011)      
Stock based compensation expense 120,604   120,604      
Distributions to non-controlling interest (48,126)       (48,126)  
Net income (loss) (4,223,455)     (4,223,455)    
Net loss 94,551       94,551  
Net income (loss) (4,318,006)          
Ending balance (shares) at Sep. 30, 2019   24,843,261        
Ending balance at Sep. 30, 2019   $ 24,843 56,573,920 (32,893,550) 112,439 23,817,652
Beginning balance (shares) at Jun. 30, 2019   24,840,806        
Beginning balance at Jun. 30, 2019   $ 24,841 56,525,590 (32,307,301) 111,291 24,354,421
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (shares)   2,455        
Exercise of stock options 5,661 $ 2 5,659      
Stock based compensation expense 42,671   42,671      
Distributions to non-controlling interest (20,713)       (20,713)  
Net income (loss) (586,249)     (586,249)    
Net loss (21,861)       (21,861)  
Net income (loss) (564,388)          
Ending balance (shares) at Sep. 30, 2019   24,843,261        
Ending balance at Sep. 30, 2019   $ 24,843 56,573,920 (32,893,550) 112,439 23,817,652
Beginning balance (shares) at Dec. 31, 2019   24,849,261        
Beginning balance at Dec. 31, 2019 23,353,277 $ 24,849 56,622,285 (33,379,114) 85,257 23,353,277
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (shares)   1,000        
Exercise of stock options 1,200 $ 1 1,199      
Stock issuance costs (1,951)   (1,951)      
Stock based compensation expense 132,312   132,312      
Distributions to non-controlling interest (41,740)       (41,740)  
Net income (loss) (2,088,195)     (2,088,195)    
Net loss (28,400)       (28,400)  
Net income (loss) (2,059,795)          
Ending balance (shares) at Sep. 30, 2020   24,850,261        
Ending balance at Sep. 30, 2020 21,383,303 $ 24,850 56,753,845 (35,467,309) 71,917 21,383,303
Beginning balance (shares) at Jun. 30, 2020   24,850,261        
Beginning balance at Jun. 30, 2020   $ 24,850 56,704,412 (35,235,389) 80,076 21,573,949
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock issuance costs (1,149)   (1,149)      
Stock based compensation expense 50,582   50,582      
Distributions to non-controlling interest (18,670)       (18,670)  
Net income (loss) (231,920)     (231,920)    
Net loss (10,511)       (10,511)  
Net income (loss) (221,409)          
Ending balance (shares) at Sep. 30, 2020   24,850,261        
Ending balance at Sep. 30, 2020 $ 21,383,303 $ 24,850 $ 56,753,845 $ (35,467,309) $ 71,917 $ 21,383,303